The Proof with Simon Hill cover image

New heart disease test you should order | Thomas Dayspring, Md

The Proof with Simon Hill

00:00

Mechanism and Impact of PCSK9 Inhibitors on LP little A Levels

This chapter explains how PCSK9 inhibitors influence LP little A levels by interacting with LDL receptors and APO-B particles, discussing the benefits of combining high-dose statins with PCSK9 inhibitors. It explores various drugs' effects on reducing ApoB and LP little a concentrations to mitigate heart disease risks, including the mechanisms of PCSK9 inhibitors, CETP inhibitors, and movalalapin.

Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner